KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Other Working Capital Changes: 2010-2024

Historic Other Working Capital Changes for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to -$1.9 million.

  • TherapeuticsMD's Other Working Capital Changes rose 13.84% to -$529,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year increase of 71.51%. This contributed to the annual value of -$1.9 million for FY2024, which is 2030.00% down from last year.
  • Latest data reveals that TherapeuticsMD reported Other Working Capital Changes of -$1.9 million as of FY2024, which was down 2,030.00% from $100,000 recorded in FY2023.
  • In the past 5 years, TherapeuticsMD's Other Working Capital Changes registered a high of $387,000 during FY2020, and its lowest value of -$1.9 million during FY2024.
  • Over the past 3 years, TherapeuticsMD's median Other Working Capital Changes value was $100,000 (recorded in 2023), while the average stood at -$551,000.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first surged by 1,388.46% in 2020, then plummeted by 2,030.00% in 2024.
  • Yearly analysis of 5 years shows TherapeuticsMD's Other Working Capital Changes stood at $387,000 in 2020, then slumped by 94.57% to $21,000 in 2021, then skyrocketed by 742.86% to $177,000 in 2022, then tumbled by 43.50% to $100,000 in 2023, then plummeted by 2,030.00% to -$1.9 million in 2024.